ARISTADA INITIO 675 mg/2.4mL
aripiprazole lauroxil · INJECTION, SUSPENSION, EXTENDED RELEASE · Alkermes, Inc.
No Recall History
Plain English
ARISTADA INITIO is a injection, suspension, extended release containing aripiprazole lauroxil at 675 mg/2.4mL, taken intramuscular. Manufactured by Alkermes, Inc..
Key Facts
- Brand Name
- ARISTADA INITIO
- Generic Name
- aripiprazole lauroxil
- NDC Code (Product)
65757-500- Manufacturer
- Alkermes, Inc.
- Strength
- 675 mg/2.4mL
- Dosage Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- NDA209830
- Marketing Start
- 06/29/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is ARISTADA INITIO used for?
ARISTADA INITIO contains aripiprazole lauroxil. It is a injection, suspension, extended release taken intramuscular. Consult your doctor for specific uses.
Is ARISTADA INITIO a controlled substance?
ARISTADA INITIO is not classified as a controlled substance by the DEA.
What is the generic name for ARISTADA INITIO?
The generic name for ARISTADA INITIO is aripiprazole lauroxil. There are 4 other brand versions of aripiprazole lauroxil.
What is the NDC code for ARISTADA INITIO 675 mg/2.4mL?
The NDC (National Drug Code) for ARISTADA INITIO 675 mg/2.4mL is 65757-500, listed by Alkermes, Inc..